Last updated: 11/07/2018 11:32:33
A Study to Investigate the Efficacy and Safety of Valaciclovir in the Treatment of Recurrent Ano-Genital Herpes in HIV-Infected Patients
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Study to Investigate the Efficacy and Safety of Valaciclovir in the Treatment of Recurrent Ano-Genital Herpes in HIV-Infected Patients
Trial description: A Study to Investigate the Efficacy and Safety of Valaciclovir in the Treatment of Recurrent Ano-Genital Herpes in HIV-Infected Patients
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Conant MA, Schacker TW, Murphy RL, Gold J, Crutchfield LT, Crooks RJ, and the International Valaciclovir HSV Study Group. “Valaciclovir versus acyclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials”. International Journal of STS & AIDS, 13: 12-21; 2002.
Valacyclovir for the Suppression of Ano-Genital Herpes Simplex Virus (HSV) Infection in HIV-Infected Persons Schacker, T; Wald, A; DeJesus, E, and Warren, T. 40th Annual Meeting of the Infectious Diseases Society of America; Chicago, IL; USA. 2002 Oct 24
Medical condition
Herpes Genitalis
Product
valaciclovir
Collaborators
Not applicable
Study date(s)
September 1991 to April 1995
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1995-26-04
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website